menu toggle

Thank you for your interest in FormularyDecisions® Enterprise

A member of our team will reach out shortly to schedule your demo

More insights

EU Flag HTA Assessments

Insight

The new EU regulation on health technology assessment: Major change or minor adjustment?

HTA Quarterly
AmerisourceBergen
August 2022

Panama Canal Orphan Drug Lock Article Image

Insight

Orphan drugs: trapped in the lock? A review of the lock system in the Netherlands

HTA Quarterly
AmerisourceBergen
May 2022

formulary decisions enterprise man working on computer

Insight

Why FormularyDecisions® is the right choice for enterprise biopharma payer engagement 


Xcenda
July 2022